Chemical Compound

(4S,4aS,5aR,12aS)-4,7-Bis(dimethylamino)-9-[[2-[(1,1-dimethylethyl)amino]acetyl]amino]-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide; Tygacil; WAY-GAR 936; Glycylcycline;

CAS Registry Number 220620-09-7
返回搜索 申请报价
(4S,4aS,5aR,12aS)-4,7-Bis(dimethylamino)-9-[[2-[(1,1-dimethylethyl)amino]acetyl]amino]-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide; Tygacil; WAY-GAR 936; Glycylcycline; 结构式
Primary record

(4S,4aS,5aR,12aS)-4,7-Bis(dimethylamino)-9-[[2-[(1,1-dimethylethyl)amino]acetyl]amino]-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide; Tygacil; WAY-GAR 936; Glycylcycline;

库存
1,132 克
纯度
98.7 %
CAS
220620-09-7

化合物标识与属性

CAS
220620-09-7
PubChem CID
54686904
SMILES
CC(C)(C)NCC(=O)NC1=CC(=C2C[C@H]3C[C@H]4[C@@H](C(=O)C(=C([C@]4(C(=O)C3=C(C2=C1O)O)O)O)C(=O)N)N(C)C)N(C)C
Canonical SMILES
CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]3(O)C(=O)C1=C2O

名称与同义词

  • Tigecycline
  • Tygacil
  • 220620-09-7
  • WAY-GAR-936
  • Tigilcycline
  • tiglicycline
  • Glycylcycline
  • Tigeciclina
  • TBG-MINO
  • Tigecycline?
  • Tygacil(TM)
  • Tigecycline [USAN]
  • Tigecycline CRS
  • Tygacil (TN)
  • GAR-936
  • Haizheng Li Xing
  • Tigecycline hydrate
  • GAR-936,Tigecycline
  • Tigecycline 95%
  • AC1NQZEU
  • Tigecycline (Standard)
  • Tigecycline hydrochloride
  • Tigecycline (JAN/USP)
  • TIGECYCLINE [MI]
  • GAR 936
  • TIGECYCLINE [INN]
  • TIGECYCLINE [JAN]
  • Tigecycline (JAN/USAN)
  • D0G4OD
  • TIGECYCLINE [VANDF]
  • 70JE2N95KR
  • TIGECYCLINE [MART.]
  • UNII-70JE2N95KR
  • MFCD00935753
  • 9-t-Butylglycylamido minocycline
  • DTXSID2048581
  • TIGECYCLINE [USP-RS]
  • TIGECYCLINE [WHO-DD]
  • cc-152
  • MLS006010079
  • SCHEMBL101795
  • SCHEMBL105082
  • SCHEMBL237962
  • CHEBI:149836
  • FPZLLRFZJZRHSY-HJYUBDRYSA-N
  • SOVUOXKZCCAWOJ-HJYUBDRYSA-N
  • TIGECYCLINE [EMA EPAR]
  • Tigecycline [USAN:INN:BAN]
  • AC1O714W
  • C29H39N5O8
  • CHEMBL376140
  • GAR936
  • orb1308145
  • 9-t-butylglycylamido-minocycline
  • DTXCID8028507
  • SCHEMBL27246570
  • SCHEMBL29699251
  • SCHEMBL30423132
  • GTPL10929
  • HSDB 8172
  • HY-B0117R
  • MSK7046
  • SYN3024
  • TIGECYCLINE [ORANGE BOOK]
  • 9-tert-Butylglycylamidominocycline
  • BCPP000045
  • HMS3714I13
  • TIGECYCLINE [EP MONOGRAPH]
  • TIGECYCLINE [USP MONOGRAPH]
  • ACT08710
  • BCP01397
  • HY-B0117
  • Tox21_112910
  • BDBM50247905
  • CT0198
  • EBC-11312
  • NSC794945
  • s1403
  • ZINC14879972
  • AKOS015895663
  • AKOS025401452
  • AKOS037643695
  • Tigecycline for system suitability CRS
  • ZINC100022633
  • ZINC102200515
  • AC-1798
  • AN-6306
  • AT10818
  • AT31636
  • CCG-270150
  • CID5282044
  • CS-1876
  • DB00560
  • NSC-794945
  • RL02680
  • Tigecycline(Discontinued,SeeC4X-1860)
  • NCGC00183095-01
  • 121GE002
  • AS-30703
  • BC677670
  • BR-73038
  • SC-20200
  • SMR002530064
  • (4S,4aS,5aR,12aS)-9-(2-(tert-butylamino)acetamido)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
  • AB0011463
  • AB2000089
  • CL 331002
  • CL-331002
  • LS-186580
  • LS-187002
  • LS-187782
  • ST2413997
  • A5226
  • AM20090708
  • CAS-220620-09-7
  • NS00011897
  • T3589
  • J1.112.522K
  • Tygacil;GAR-936;WAY-GAR-936;TBG-MINO
  • C12012
  • D01079
  • N,N-Dimethyl-p-phenylenediamine dihydrochloride
  • S-5066
  • (4S,4aS,5aR,12aS)-9-(2-(tert-butylamino)acetamido)-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide
  • AB01566818_01
  • 620T097
  • EN300-19769236
  • Q420595
  • I06-1089
  • (4S,4aS,5aR,12aR)-9-[[2-(tert-butylamino)acetyl]amino]-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide
  • (4S,4aS,5aR,12aS)-9-[(N-tert-butylglycyl)amino]-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
  • (4S,4aS,5aR,12aS)-9-[2-(tert-butylamino)acetamido]-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
  • Tygacil, GAR-936, WAY-GAR-936, TBG-MINO, Tigecycline
  • (4S,4aS,5aR,12aS)-9-(2-(tert-Butylamino)acetamido)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1
  • (4S,12aS)-4,7-Bis(dimethylamino)-9-{2-[(tert-butyl)amino]acetylamino}-3,10,12,12a-tetrahydroxy-1,11-dioxo-4,5,6,12a,4a,5a-hexahydronaphthacene-2-carboxamide
  • (4S,4AS,5aR,12aS)-9-(2-(tert-butylamino)acetamido)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxa
  • 2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-9-((((1,1-dimethylethyl)amino)acetyl)amino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4S,4aS,5aR,12aS)-
  • N-[(5aR,6aS,7S,9Z,10aS)-9-[amino(hydroxy)methylidene]-4,7-bis(dimethylamino)-1,10a,12-trihydroxy-8,10,11-trioxo-5a,6,6a,7-tetrahydro-5H-tetracen-2-yl]-2-(tert-butylamino)acetamide
  • 7-(Dimethylamino)-9-(N-tert-butylglycylamino)-6-demethyl-6-deoxytetracycline
  • (1S)-8-[2-(tert-Butylamino)acetylamino]-3-carbamoyl-1,4a,11,11aalpha,12,12aalpha-hexahydro-2,4aalpha,5,7-tetrahydroxy-1alpha,10-bis(dimethylamino)naphthacene-4,6-dione
  • (1S,4aS,11aR,12aS)-8-[2-(tert-Butylamino)acetylamino]-3-carbamoyl-1,4a,11,11a,12,12a-hexahydro-2,4a,5,7-tetrahydroxy-1,10-bis(dimethylamino)naphthacene-4,6-dione
  • (4S,4aS,5aR,12aS)-4,7-Bis(dimethylamino)-9-[[2-[(1,1-dimethylethyl)amino]acetyl]amino]-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide
  • (4S,4aS,5aR,12aS)-4,7-Bis(dimethylamino)-9-[[2-[(1,1-dimethylethyl)amino]acetyl]amino]-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide; Tygacil; WAY-GAR 936; Glycylcycline;
  • (4s,4as,5ar,12as)-9-(2-t-butylaminoacetylamino)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydronaphthacene-2-carboxamide
  • (4S,4aS,5aR,12aS)-9-[[2-(tert-butylamino)acetyl]amino]-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide
  • (4s,4as,5ar,12as)-9-[2-(tert-butylamino)acetamido]-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide
  • 197654-04-9
  • 2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-9-((((1,1-dimethylethyl)amino)acetyl)amino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4S,4aS,5aR,12aS)-
  • 2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-9-((2-((1,1-dimethylethyl)amino)acetyl)amino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4S,4aS,5aR,12aS)-
  • 2-NAPHTHACENECARBOXAMIDE, 4,7-BIS(DIMETHYLAMINO)-9-[[[(1,1-DIMETHYLETHYL)AMINO]ACETYL]AMINO]-1,4,4A,5,5A,6,11,12A-OCTAHYDRO-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-, (4S,4AS,5AR,12AS)-
  • 2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-9-[[2-[(1,1-dimethylethyl)amino]acetyl]amino]-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4S,4aS,5aR,12aS)-
  • 2-Naphthacenecarboxamide,4,7-bis(dimethylamino)-9-[[2-[(1,1-dimethylethyl)amino]acetyl]amino]-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-,(4S,4aS,5aR,12aS)-
  • N-((5aR,6aS,7S,10aS,Z)-9-(amino(hydroxy)methylene)-4,7-bis(dimethylamino)-1,10a,12-trihydroxy-8,10,11-trioxo-5,5a,6,6a,7,8,9,10,10a,11-decahydrotetracen-2-yl)-2-(tert-butylamino)acetamide
  • N-[(5aR,6aS,7S,9E,10aS)-9-[amino(hydroxy)methylidene]-4,7-bis(dimethylamino)-1,10a,12-trihydroxy-8,10,11-trioxo-5a,6,6a,7-tetrahydro-5H-tetracen-2-yl]-2-(tert-butylamino)acetamide
  • N-[(5aR,6aS,7S,9Z,10aS)-9-[amino(hydroxy)methylene]-4,7-bis(dimethylamino)-1,10a,12-trihydroxy-8,10,11-trioxo-5a,6,6a,7-tetrahydro-5H-tetracen-2-yl]-2-(tert-butylamino)acetamide
  • T1C
  • TGC